Endo International plc (ENDPQ)
OTCMKTS: ENDPQ · Delayed Price · USD
0.0006
0.00 (0.00%)
May 1, 2024, 2:16 PM EDT - Market closed
Endo International Revenue
In the year 2023, Endo International had annual revenue of $2.01B, a decrease of -13.25%. Revenue in the quarter ending December 31, 2023 was $497.73M, a -10.45% decrease year-over-year.
Revenue (ttm)
$2.01B
Revenue Growth
-13.25%
P/S Ratio
0.00
Revenue / Employee
$686,291
Employees
2,931
Market Cap
141.13K USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.01B | -307.36M | -13.25% |
Dec 31, 2022 | 2.32B | -674.33M | -22.53% |
Dec 31, 2021 | 2.99B | 90.13M | 3.10% |
Dec 31, 2020 | 2.90B | -11.29M | -0.39% |
Dec 31, 2019 | 2.91B | -32.71M | -1.11% |
Dec 31, 2018 | 2.95B | -521.78M | -15.04% |
Dec 31, 2017 | 3.47B | -541.42M | -13.50% |
Dec 31, 2016 | 4.01B | 741.56M | 22.69% |
Dec 31, 2015 | 3.27B | 391.53M | 13.61% |
Dec 31, 2014 | 2.88B | 260.28M | 9.95% |
Dec 31, 2013 | 2.62B | -410.46M | -13.56% |
Dec 31, 2012 | 3.03B | 297.24M | 10.89% |
Dec 31, 2011 | 2.73B | 1.01B | 59.08% |
Dec 31, 2010 | 1.72B | 255.39M | 17.48% |
Dec 31, 2009 | 1.46B | 200.31M | 15.89% |
Dec 31, 2008 | 1.26B | 174.93M | 16.11% |
Dec 31, 2007 | 1.09B | 175.95M | 19.34% |
Dec 31, 2006 | 909.66M | 89.50M | 10.91% |
Dec 31, 2005 | 820.16M | 205.06M | 33.34% |
Dec 31, 2004 | 615.10M | 19.49M | 3.27% |
Dec 31, 2003 | 595.61M | 196.64M | 49.29% |
Dec 31, 2002 | 398.97M | 146.99M | 58.34% |
Dec 31, 2001 | 251.98M | 54.55M | 27.63% |
Dec 31, 2000 | 197.43M | 58.88M | 42.50% |
Dec 31, 1999 | 138.55M | 30.18M | 27.85% |
Dec 31, 1998 | 108.37M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 85.16B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.11B |
ENDPQ News
- 9 days ago - Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution - PRNewsWire
- 5 weeks ago - Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS® - PRNewsWire
- 6 weeks ago - Drugmaker Endo receives US court approval for bankruptcy restructuring - Reuters
- 6 weeks ago - Endo Announces Confirmation of Plan of Reorganization - PRNewsWire
- 7 weeks ago - Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution - PRNewsWire
- 2 months ago - ENDO REPORTS FOURTH-QUARTER 2023 FINANCIAL RESULTS - PRNewsWire
- 2 months ago - Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER - PRNewsWire
- 2 months ago - Drugmaker Endo reaches $465 mln bankruptcy settlement with US government - Reuters